 |
|
|
|
|
History
Argos Therapeutics, incorporated in 1997 and formerly known as Merix
Bioscience, traces its roots to Duke University, where Company founders
developed a unique RNA-based technology.
With a broad technology platform,
a diverse syndicate of top-tier life science investors, and key corporate
partnerships and collaborations with some of the world’s leading experts in immunotherapy, Argos
is positioned at the convergence of the scientific, clinical and investor
communities and their rapidly expanding interest in autologous, patient-specific
immunotherapeutics. Argos’ relationships with leading global scientific,
academic and commercial entities add to its strength.
Argos Therapeutics
is headquartered in Durham, North Carolina.
|
|
 |
|
